TrialDrug and alcohol dependence2010

Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.

Amit Chakrabarti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.